Special items: Ovarian Cancer and Us blog best viewed in Firefox

Thursday, March 10, 2011

Bevacizumab Doubles Risk of GI Adverse Events in Key Ovarian Cancer Trial  : Internal Medicine News SGO/Dr Burger/O'Malley


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.